Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RITA-MI 2: Rituximab in Patients With ST-elevation Myocardial Infarction
NCT05211401Phase 2Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2022
- Primary completion
- Nov 2027
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in ST elevation myocardial infarction (STEMI), sponsored by Assistance publique - Hôpitaux de Paris. Started Jun 2022; status: recruiting.
02
Drugs
rituximab
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT05211401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05211401.